Sort
38,696 grants matching “als”
Heparan Sulfate in Schwann Cell Development and Myelination
$390,757Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · HD
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION
$390,750Emanuela Gussoni · Boston Children'S Hospital · R01 · FY2011 · AR
MGE Progenitor Cell Grafts and Epilepsy
$390,720University Of California San Francisco · R01 · FY2005 · NS
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
$390,660Xuefeng Liu · Ohio State University · R33 · FY2021 · CA
Multi-modal Treatment of Fragile X Syndrome: From Cell to Child
$390,653Randi J Hagerman · University Of California At Davis · U54 · FY2016 · HD
Survival Motor Neuron (SMN) function in motoneuron development
$390,609Christine E Beattie · Ohio State University · R01 · FY2017 · NS
Identification and validation of targets for therapeutic intervention in rare diseases of intermediary metabolism
$390,596Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2018 · TR
The role of DNA damage and repair at telomeres
$390,571Yie Liu · National Institute On Aging · ZIA · FY2016 · AG
Do State Regulations Affect the Outcomes of Assisted Living Residents with Dementia?
$390,532Kali St. Marie Thomas · Brown University · R01 · FY2020 · AG
Pediatric CFS in a Community-Based Sample
$390,527Leonard A Jason · De Paul University · R01 · FY2015 · HD
The Receptor Basis for Serotonergic Modulation of Olfaction Across Multiple Brain Areas
$390,514Andrew M Dacks · West Virginia University · R01 · FY2021 · DC
The Receptor Basis for Serotonergic Modulation of Olfaction Across Multiple Brain Areas
$390,514Andrew M Dacks · West Virginia University · R01 · FY2020 · DC
Prefrontal Function in Adolescent Limited vs Life Course Persistent SUD
$390,503Michael Damingo De Bellis · Duke University · R01 · FY2012 · DA
Identification, cloning, and in vitro characterization of transmitted/founder vir
$390,489Beatrice H Hahn · University Of Pennsylvania · P01 · FY2012 · AI
Genetic and Molecular Analysis of Mouse Mutants with Congenital Heart Defects
$390,462Ivan Paul Moskowitz · University Of Chicago · R01 · FY2010 · HL
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS
$390,449Duke University · R01 · FY2002 · AG
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$390,425Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
Pathological signatures of CHCHD10 dysfunction in ADRDs
$390,425David E Kang · Case Western Reserve University · R01 · FY2024 · NS
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
$390,367Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2014 · FD
Genetic and Molecular Analysis of Mouse Mutants with Congenital Heart Defects
$390,291Ivan Paul Moskowitz · University Of Chicago · R01 · FY2009 · HL
isomiRGate: a comprehensive gateway for studying the canonical and modified microRNAomes in Cancer
$390,290Giovanni Nigita · Ohio State University · R21 · FY2024 · CA
Co-translational ER quality control
$390,275Peter Walter · University Of California, San Francisco · R01 · FY2017 · GM
Dietary Modification Of Brain Aging And Neurodegenerative Disorders
$390,204Mark Mattson · National Institute On Aging · ZIA · FY2012 · AG
Endothelialized microfluidics for sickle cell disease research & drug discovery
$390,164Wilbur A Lam · Emory University · R01 · FY2016 · HL
Endothelialized microfluidics for sickle cell disease research & drug discovery
$390,164Wilbur A Lam · Emory University · R01 · FY2018 · HL